Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
Lynn R. Webster(Adherent Technologies (United States)), A. L. Finn(BioDelivery Sciences International (United States)), Michael Camilleri(CSIRO Manufacturing)
Cited by 13
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504